{"data":{"object":"corporate_constellation","provenance":"CNXTD By #://CNXTAi_x_#://CHaTx","connectedIdentityBasis":"Provable shared hard identifiers only (ISO 17442 LEI, GLEIF Level 1/2/3, ISO 6166 ISIN, 9-char US/CA CUSIP, ISO 9362 SWIFT BIC, SEC EDGAR CIK / Form N-CEN LEI, IANA PEN / RDAP TLD, and NRO/ARIN number resources). Zero fuzzy or name-similarity matching.","subject":{"kind":"gleif","name":"PERRIGO COMPANY PUBLIC LIMITED COMPANY","orgSource":"gleif","orgKey":"549300IFOQS6R1QLY196","orgAddress":"#://CNXTTHePeoPLe/ORG/GLEIF/549300IFOQS6R1QLY196","orgPath":"/orgs/gleif/549300IFOQS6R1QLY196","lei":"549300IFOQS6R1QLY196","leiPath":"/lei/549300IFOQS6R1QLY196","cik":null,"ticker":null,"isin":null,"pen":null,"asn":null,"domain":null,"country":"IE","edition":{"editionSlug":"org-gleif-549300ifoqs6r1qly196","editionPath":"/apps/org-gleif-549300ifoqs6r1qly196","editionAddress":"web+usd://org-gleif-549300ifoqs6r1qly196","gtin14":"29440400418169","minted":false,"mintFeeCents":20000}},"summary":{"gleifFamilyTotal":18,"isinTotal":7,"cusipShown":7,"bicShown":1,"secTickersShown":0,"ncenRolesShown":0,"penShown":0,"arinResourcesShown":0,"boundedPageLimit":100},"rails":{"gleif":{"level1":{"lei":"549300IFOQS6R1QLY196","legalName":"PERRIGO COMPANY PUBLIC LIMITED COMPANY","entityStatus":"ACTIVE","entityCategory":"GENERAL","registrationStatus":"ISSUED","jurisdiction":"IE","initialRegistrationDate":"2013-08-05T16:57:00+00:00","nextRenewalDate":"2027-10-10T14:25:44+00:00","legalForm":{"code":"VYAX","name":"Public Limited Company","transliteratedName":null,"abbreviation":null,"other":null},"registrationAuthority":{"code":"RA000402","name":"Companies Register","localName":"Companies Register","organization":"Companies Registration Office","localOrganization":"Companies Registration Office","website":"http://www.cro.ie/","jurisdictions":[{"country":"Ireland","countryCode":"IE","jurisdiction":"Ireland"}],"entityId":"529592","other":null},"nomineeAliases":[],"leiPath":"/lei/549300IFOQS6R1QLY196","orgPath":"/orgs/gleif/549300IFOQS6R1QLY196","edition":{"editionSlug":"org-gleif-549300ifoqs6r1qly196","editionPath":"/apps/org-gleif-549300ifoqs6r1qly196","editionAddress":"web+usd://org-gleif-549300ifoqs6r1qly196","gtin14":"29440400418169","minted":false,"mintFeeCents":20000}},"level2":{"status":"complete","asOf":"2026-11-20T01:33:48.691Z","ultimateParents":[],"directParents":[],"directChildren":{"total":9,"shown":9,"listPath":"/orgs/gleif/549300IFOQS6R1QLY196/family/direct-children","items":[{"lei":"213800BFQKQDRNGYCD28","name":"GALPHARM INTERNATIONAL LIMITED","relationship":"IS_DIRECTLY_CONSOLIDATED_BY","relationshipLabel":"Direct Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2014-02-17","periodEnd":null,"leiPath":"/lei/213800BFQKQDRNGYCD28","orgPath":"/orgs/gleif/213800BFQKQDRNGYCD28","resolvePath":"/resolve?q=213800BFQKQDRNGYCD28","edition":{"editionSlug":"org-gleif-213800bfqkqdrngycd28","editionPath":"/apps/org-gleif-213800bfqkqdrngycd28","editionAddress":"web+usd://org-gleif-213800bfqkqdrngycd28","gtin14":"29849689738560","minted":false,"mintFeeCents":20000}},{"lei":"213800HETP32VSE8XH57","name":"PERRIGO UK ACQUISITION LIMITED","relationship":"IS_DIRECTLY_CONSOLIDATED_BY","relationshipLabel":"Direct Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2014-02-17","periodEnd":null,"leiPath":"/lei/213800HETP32VSE8XH57","orgPath":"/orgs/gleif/213800HETP32VSE8XH57","resolvePath":"/resolve?q=213800HETP32VSE8XH57","edition":{"editionSlug":"org-gleif-213800hetp32vse8xh57","editionPath":"/apps/org-gleif-213800hetp32vse8xh57","editionAddress":"web+usd://org-gleif-213800hetp32vse8xh57","gtin14":"29364460744320","minted":false,"mintFeeCents":20000}},{"lei":"213800KVIAMVFVSPP466","name":"WRAFTON LABORATORIES LIMITED","relationship":"IS_DIRECTLY_CONSOLIDATED_BY","relationshipLabel":"Direct Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2014-02-17","periodEnd":null,"leiPath":"/lei/213800KVIAMVFVSPP466","orgPath":"/orgs/gleif/213800KVIAMVFVSPP466","resolvePath":"/resolve?q=213800KVIAMVFVSPP466","edition":{"editionSlug":"org-gleif-213800kviamvfvspp466","editionPath":"/apps/org-gleif-213800kviamvfvspp466","editionAddress":"web+usd://org-gleif-213800kviamvfvspp466","gtin14":"29751733577646","minted":false,"mintFeeCents":20000}},{"lei":"5493002HHHFTG6G3BG36","name":"OMEGA PHARMA NV","relationship":"IS_DIRECTLY_CONSOLIDATED_BY","relationshipLabel":"Direct Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2017-11-28","periodEnd":null,"leiPath":"/lei/5493002HHHFTG6G3BG36","orgPath":"/orgs/gleif/5493002HHHFTG6G3BG36","resolvePath":"/resolve?q=5493002HHHFTG6G3BG36","edition":{"editionSlug":"org-gleif-5493002hhhftg6g3bg36","editionPath":"/apps/org-gleif-5493002hhhftg6g3bg36","editionAddress":"web+usd://org-gleif-5493002hhhftg6g3bg36","gtin14":"29441505497561","minted":false,"mintFeeCents":20000}},{"lei":"5493007OJ9DBG3DTWD16","name":"PERRIGO CAPITAL","relationship":"IS_DIRECTLY_CONSOLIDATED_BY","relationshipLabel":"Direct Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2017-11-23","periodEnd":null,"leiPath":"/lei/5493007OJ9DBG3DTWD16","orgPath":"/orgs/gleif/5493007OJ9DBG3DTWD16","resolvePath":"/resolve?q=5493007OJ9DBG3DTWD16","edition":{"editionSlug":"org-gleif-5493007oj9dbg3dtwd16","editionPath":"/apps/org-gleif-5493007oj9dbg3dtwd16","editionAddress":"web+usd://org-gleif-5493007oj9dbg3dtwd16","gtin14":"29079532850570","minted":false,"mintFeeCents":20000}},{"lei":"549300AWJ82D3ANYK281","name":"OMEGA PHARMA INVEST NV","relationship":"IS_DIRECTLY_CONSOLIDATED_BY","relationshipLabel":"Direct Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2017-06-15","periodEnd":null,"leiPath":"/lei/549300AWJ82D3ANYK281","orgPath":"/orgs/gleif/549300AWJ82D3ANYK281","resolvePath":"/resolve?q=549300AWJ82D3ANYK281","edition":{"editionSlug":"org-gleif-549300awj82d3anyk281","editionPath":"/apps/org-gleif-549300awj82d3anyk281","editionAddress":"web+usd://org-gleif-549300awj82d3anyk281","gtin14":"29935997752883","minted":false,"mintFeeCents":20000}},{"lei":"549300E86RB6YCTMRM83","name":"PERRIGO FINANCE UNLIMITED COMPANY","relationship":"IS_DIRECTLY_CONSOLIDATED_BY","relationshipLabel":"Direct Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2017-06-23","periodEnd":null,"leiPath":"/lei/549300E86RB6YCTMRM83","orgPath":"/orgs/gleif/549300E86RB6YCTMRM83","resolvePath":"/resolve?q=549300E86RB6YCTMRM83","edition":{"editionSlug":"org-gleif-549300e86rb6yctmrm83","editionPath":"/apps/org-gleif-549300e86rb6yctmrm83","editionAddress":"web+usd://org-gleif-549300e86rb6yctmrm83","gtin14":"29509229959489","minted":false,"mintFeeCents":20000}},{"lei":"549300POZGC78VHAAJ73","name":"Perrigo Investments, LLC","relationship":"IS_DIRECTLY_CONSOLIDATED_BY","relationshipLabel":"Direct Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2022-03-09","periodEnd":null,"leiPath":"/lei/549300POZGC78VHAAJ73","orgPath":"/orgs/gleif/549300POZGC78VHAAJ73","resolvePath":"/resolve?q=549300POZGC78VHAAJ73","edition":{"editionSlug":"org-gleif-549300pozgc78vhaaj73","editionPath":"/apps/org-gleif-549300pozgc78vhaaj73","editionAddress":"web+usd://org-gleif-549300pozgc78vhaaj73","gtin14":"29160171747601","minted":false,"mintFeeCents":20000}},{"lei":"699400OM0TR7QPJXCY11","name":"OMEGA PHARMA BELGIUM","relationship":"IS_DIRECTLY_CONSOLIDATED_BY","relationshipLabel":"Direct Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2019-01-01","periodEnd":null,"leiPath":"/lei/699400OM0TR7QPJXCY11","orgPath":"/orgs/gleif/699400OM0TR7QPJXCY11","resolvePath":"/resolve?q=699400OM0TR7QPJXCY11","edition":{"editionSlug":"org-gleif-699400om0tr7qpjxcy11","editionPath":"/apps/org-gleif-699400om0tr7qpjxcy11","editionAddress":"web+usd://org-gleif-699400om0tr7qpjxcy11","gtin14":"29562326525353","minted":false,"mintFeeCents":20000}}]},"ultimateChildren":{"total":9,"shown":9,"items":[{"lei":"213800BFQKQDRNGYCD28","name":"GALPHARM INTERNATIONAL LIMITED","relationship":"IS_ULTIMATELY_CONSOLIDATED_BY","relationshipLabel":"Ultimate Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2014-02-17","periodEnd":null,"leiPath":"/lei/213800BFQKQDRNGYCD28","orgPath":"/orgs/gleif/213800BFQKQDRNGYCD28","resolvePath":"/resolve?q=213800BFQKQDRNGYCD28","edition":{"editionSlug":"org-gleif-213800bfqkqdrngycd28","editionPath":"/apps/org-gleif-213800bfqkqdrngycd28","editionAddress":"web+usd://org-gleif-213800bfqkqdrngycd28","gtin14":"29849689738560","minted":false,"mintFeeCents":20000}},{"lei":"213800HETP32VSE8XH57","name":"PERRIGO UK ACQUISITION LIMITED","relationship":"IS_ULTIMATELY_CONSOLIDATED_BY","relationshipLabel":"Ultimate Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2014-02-17","periodEnd":null,"leiPath":"/lei/213800HETP32VSE8XH57","orgPath":"/orgs/gleif/213800HETP32VSE8XH57","resolvePath":"/resolve?q=213800HETP32VSE8XH57","edition":{"editionSlug":"org-gleif-213800hetp32vse8xh57","editionPath":"/apps/org-gleif-213800hetp32vse8xh57","editionAddress":"web+usd://org-gleif-213800hetp32vse8xh57","gtin14":"29364460744320","minted":false,"mintFeeCents":20000}},{"lei":"213800KVIAMVFVSPP466","name":"WRAFTON LABORATORIES LIMITED","relationship":"IS_ULTIMATELY_CONSOLIDATED_BY","relationshipLabel":"Ultimate Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2014-02-17","periodEnd":null,"leiPath":"/lei/213800KVIAMVFVSPP466","orgPath":"/orgs/gleif/213800KVIAMVFVSPP466","resolvePath":"/resolve?q=213800KVIAMVFVSPP466","edition":{"editionSlug":"org-gleif-213800kviamvfvspp466","editionPath":"/apps/org-gleif-213800kviamvfvspp466","editionAddress":"web+usd://org-gleif-213800kviamvfvspp466","gtin14":"29751733577646","minted":false,"mintFeeCents":20000}},{"lei":"5493002HHHFTG6G3BG36","name":"OMEGA PHARMA NV","relationship":"IS_ULTIMATELY_CONSOLIDATED_BY","relationshipLabel":"Ultimate Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2017-11-28","periodEnd":null,"leiPath":"/lei/5493002HHHFTG6G3BG36","orgPath":"/orgs/gleif/5493002HHHFTG6G3BG36","resolvePath":"/resolve?q=5493002HHHFTG6G3BG36","edition":{"editionSlug":"org-gleif-5493002hhhftg6g3bg36","editionPath":"/apps/org-gleif-5493002hhhftg6g3bg36","editionAddress":"web+usd://org-gleif-5493002hhhftg6g3bg36","gtin14":"29441505497561","minted":false,"mintFeeCents":20000}},{"lei":"5493007OJ9DBG3DTWD16","name":"PERRIGO CAPITAL","relationship":"IS_ULTIMATELY_CONSOLIDATED_BY","relationshipLabel":"Ultimate Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2017-11-23","periodEnd":null,"leiPath":"/lei/5493007OJ9DBG3DTWD16","orgPath":"/orgs/gleif/5493007OJ9DBG3DTWD16","resolvePath":"/resolve?q=5493007OJ9DBG3DTWD16","edition":{"editionSlug":"org-gleif-5493007oj9dbg3dtwd16","editionPath":"/apps/org-gleif-5493007oj9dbg3dtwd16","editionAddress":"web+usd://org-gleif-5493007oj9dbg3dtwd16","gtin14":"29079532850570","minted":false,"mintFeeCents":20000}},{"lei":"549300AWJ82D3ANYK281","name":"OMEGA PHARMA INVEST NV","relationship":"IS_ULTIMATELY_CONSOLIDATED_BY","relationshipLabel":"Ultimate Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2017-06-15","periodEnd":null,"leiPath":"/lei/549300AWJ82D3ANYK281","orgPath":"/orgs/gleif/549300AWJ82D3ANYK281","resolvePath":"/resolve?q=549300AWJ82D3ANYK281","edition":{"editionSlug":"org-gleif-549300awj82d3anyk281","editionPath":"/apps/org-gleif-549300awj82d3anyk281","editionAddress":"web+usd://org-gleif-549300awj82d3anyk281","gtin14":"29935997752883","minted":false,"mintFeeCents":20000}},{"lei":"549300E86RB6YCTMRM83","name":"PERRIGO FINANCE UNLIMITED COMPANY","relationship":"IS_ULTIMATELY_CONSOLIDATED_BY","relationshipLabel":"Ultimate Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2017-06-23","periodEnd":null,"leiPath":"/lei/549300E86RB6YCTMRM83","orgPath":"/orgs/gleif/549300E86RB6YCTMRM83","resolvePath":"/resolve?q=549300E86RB6YCTMRM83","edition":{"editionSlug":"org-gleif-549300e86rb6yctmrm83","editionPath":"/apps/org-gleif-549300e86rb6yctmrm83","editionAddress":"web+usd://org-gleif-549300e86rb6yctmrm83","gtin14":"29509229959489","minted":false,"mintFeeCents":20000}},{"lei":"549300POZGC78VHAAJ73","name":"Perrigo Investments, LLC","relationship":"IS_ULTIMATELY_CONSOLIDATED_BY","relationshipLabel":"Ultimate Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2022-03-09","periodEnd":null,"leiPath":"/lei/549300POZGC78VHAAJ73","orgPath":"/orgs/gleif/549300POZGC78VHAAJ73","resolvePath":"/resolve?q=549300POZGC78VHAAJ73","edition":{"editionSlug":"org-gleif-549300pozgc78vhaaj73","editionPath":"/apps/org-gleif-549300pozgc78vhaaj73","editionAddress":"web+usd://org-gleif-549300pozgc78vhaaj73","gtin14":"29160171747601","minted":false,"mintFeeCents":20000}},{"lei":"699400OM0TR7QPJXCY11","name":"OMEGA PHARMA BELGIUM","relationship":"IS_ULTIMATELY_CONSOLIDATED_BY","relationshipLabel":"Ultimate Subsidiary","direction":"down","status":"ACTIVE","periodStart":"2019-01-01","periodEnd":null,"leiPath":"/lei/699400OM0TR7QPJXCY11","orgPath":"/orgs/gleif/699400OM0TR7QPJXCY11","resolvePath":"/resolve?q=699400OM0TR7QPJXCY11","edition":{"editionSlug":"org-gleif-699400om0tr7qpjxcy11","editionPath":"/apps/org-gleif-699400om0tr7qpjxcy11","editionAddress":"web+usd://org-gleif-699400om0tr7qpjxcy11","gtin14":"29562326525353","minted":false,"mintFeeCents":20000}}]},"branchesAndFunds":{"total":0,"shown":0,"items":[]}},"level3":{"status":"complete","asOf":"2026-11-20T02:02:43.387Z","directParentExceptions":[{"code":"NO_KNOWN_PERSON","text":"no known person"}],"ultimateParentExceptions":[{"code":"NO_KNOWN_PERSON","text":"no known person"}]}},"securities":{"totalIsins":7,"shownIsins":7,"shownCusips":7,"listPath":"/orgs/gleif/549300IFOQS6R1QLY196/securities","items":[{"isin":"US2841311333","cusip":"284131133","prefix":"US","countryName":"United States","issuerLei":"549300IFOQS6R1QLY196","checkDigitValid":true,"recordPath":"/apps/isin-us2841311333","resolvePath":"/resolve?q=US2841311333","edition":{"editionSlug":"isin-us2841311333","editionPath":"/apps/isin-us2841311333","editionAddress":"web+usd://isin-us2841311333","gtin14":"29810015049667","minted":false,"mintFeeCents":20000}},{"isin":"US2841312083","cusip":"284131208","prefix":"US","countryName":"United States","issuerLei":"549300IFOQS6R1QLY196","checkDigitValid":true,"recordPath":"/apps/isin-us2841312083","resolvePath":"/resolve?q=US2841312083","edition":{"editionSlug":"isin-us2841312083","editionPath":"/apps/isin-us2841312083","editionAddress":"web+usd://isin-us2841312083","gtin14":"29463390156644","minted":false,"mintFeeCents":20000}},{"isin":"US2841315052","cusip":"284131505","prefix":"US","countryName":"United States","issuerLei":"549300IFOQS6R1QLY196","checkDigitValid":true,"recordPath":"/apps/isin-us2841315052","resolvePath":"/resolve?q=US2841315052","edition":{"editionSlug":"isin-us2841315052","editionPath":"/apps/isin-us2841315052","editionAddress":"web+usd://isin-us2841315052","gtin14":"29319628267838","minted":false,"mintFeeCents":20000}},{"isin":"US2841318023","cusip":"284131802","prefix":"US","countryName":"United States","issuerLei":"549300IFOQS6R1QLY196","checkDigitValid":true,"recordPath":"/apps/isin-us2841318023","resolvePath":"/resolve?q=US2841318023","edition":{"editionSlug":"isin-us2841318023","editionPath":"/apps/isin-us2841318023","editionAddress":"web+usd://isin-us2841318023","gtin14":"29058547488275","minted":false,"mintFeeCents":20000}},{"isin":"US714294AG03","cusip":"714294AG0","prefix":"US","countryName":"United States","issuerLei":"549300IFOQS6R1QLY196","checkDigitValid":true,"recordPath":"/apps/isin-us714294ag03","resolvePath":"/resolve?q=US714294AG03","edition":{"editionSlug":"isin-us714294ag03","editionPath":"/apps/isin-us714294ag03","editionAddress":"web+usd://isin-us714294ag03","gtin14":"29469781229331","minted":false,"mintFeeCents":20000}},{"isin":"US714294AH85","cusip":"714294AH8","prefix":"US","countryName":"United States","issuerLei":"549300IFOQS6R1QLY196","checkDigitValid":true,"recordPath":"/apps/isin-us714294ah85","resolvePath":"/resolve?q=US714294AH85","edition":{"editionSlug":"isin-us714294ah85","editionPath":"/apps/isin-us714294ah85","editionAddress":"web+usd://isin-us714294ah85","gtin14":"29726357225532","minted":false,"mintFeeCents":20000}},{"isin":"USG97822AD58","cusip":"G97822AD5","prefix":"US","countryName":"United States","issuerLei":"549300IFOQS6R1QLY196","checkDigitValid":true,"recordPath":"/apps/isin-usg97822ad58","resolvePath":"/resolve?q=USG97822AD58","edition":{"editionSlug":"isin-usg97822ad58","editionPath":"/apps/isin-usg97822ad58","editionAddress":"web+usd://isin-usg97822ad58","gtin14":"29925284666139","minted":false,"mintFeeCents":20000}}]},"swiftBic":{"totalShown":1,"items":[{"bic":"OMEGBE9AXXX","bic8":"OMEGBE9A","countryCode":"BE","holderLei":"5493007OJ9DBG3DTWD16","holderName":"PERRIGO CAPITAL","relation":"subsidiary","certainty":"certified","linkEditionSlug":"link-5493007oj9dbg3dtwd16","recordPath":"/apps/link-5493007oj9dbg3dtwd16","resolvePath":"/resolve?q=OMEGBE9AXXX","edition":{"editionSlug":"link-5493007oj9dbg3dtwd16","editionPath":"/apps/link-5493007oj9dbg3dtwd16","editionAddress":"web+usd://link-5493007oj9dbg3dtwd16","gtin14":"29077676741082","minted":false,"mintFeeCents":20000}}]},"secEdgar":{"primaryCik":null,"edgarUrl":null,"tickers":[],"companyReports":null,"ncenRoles":[],"identityLinks":[{"slug":"link-5493007oj9dbg3dtwd16","kind":"bic","name":"LEI 5493007OJ9DBG3DTWD16","lei":"5493007OJ9DBG3DTWD16","cik":null,"ticker":null,"bic":"OMEGBE9AXXX","edition":{"editionSlug":"link-5493007oj9dbg3dtwd16","editionPath":"/apps/link-5493007oj9dbg3dtwd16","editionAddress":"web+usd://link-5493007oj9dbg3dtwd16","gtin14":"29077676741082","minted":false,"mintFeeCents":20000}}]},"iana":{"pens":[],"icannRegistrarId":null,"domain":null,"tld":null,"rdapServers":[],"gtin14Anchor":"29440400418169"},"arin":{"queriedAsn":null,"allocations":[],"sovereignNetworxSpec":null}},"computedInMs":56.07}}